Topic Review
Sarcopenia and Approaches
Sarcopenia, an age-related decline in skeletal muscle mass and function, dramatically affects the quality of life. Although there is a consensus that sarcopenia is a multifactorial syndrome, the etiology and underlying mechanisms are not yet delineated. Moreover, research about nutritional interventions to prevent the development of sarcopenia is mainly focused on the amount and quality of protein intake. The impact of several nutrition strategies that consider timing of food intake, anti-inflammatory nutrients, metabolic control, and the role of mitochondrial function on the progression of sarcopenia is not fully understood. This narrative review summarizes the metabolic background of this phenomenon and proposes an integral nutritional approach (including dietary supplements such as creatine monohydrate) to target potential molecular pathways that may affect reduce or ameliorate the adverse effects of sarcopenia. Lastly, miRNAs, in particular those produced by skeletal muscle (MyomiR), might represent a valid tool to evaluate sarcopenia progression as a potential rapid and early biomarker for diagnosis and characterization. 
  • 455
  • 24 Sep 2021
Topic Review
Sarcoma Metabolomics
Sarcoma metabolomics is a broadly unexplored field that can offer diverse opportunities. Deeper characterization and a sharper picture of sarcoma metabolic and microenvironment landscape may pave the way for diagnostic and staging refinement and identification of new potential therapeutic targets, resulting in benefits for patients.
  • 498
  • 02 Jul 2021
Topic Review
Sample Entropy
Sample entropy, fractal dimension, Lyapunov exponent used as nonlinear measures, and assessment of the variability of the center of pressure during standing using force plate. 
  • 725
  • 14 Dec 2020
Topic Review
Salivary Gland Tissue Engineering Approaches
Salivary gland regeneration is important for developing treatments for radiation-induced xerostomia, Sjögren’s syndrome, and other conditions that cause dry mouth. Culture conditions adopted from tissue engineering strategies have been used to recapitulate gland structure and function to study and regenerate the salivary glands. The purpose of this review is to highlight current trends in the field, with an emphasis on soluble factors that have been shown to improve secretory function in vitro.
  • 416
  • 21 Jul 2021
Topic Review
SAHA
Suberoylanilide hydroxamic acid (SAHA) inhibits class I and II HDACs by binding to the Zn2+ chelation center in the enzyme and affects processes that lead to cell cycle arrest and apoptosis .However, in Phase II studies, SAHA has demonstrated little to no efficacy either alone or in combination with standard anti-cancer treatments. Several factors may cause the lack of HDAC response including low stability in the blood stream (two-hour elimination half-life) and an inability to accumulate adequate concentrations at the tumor site, a combination of increased drug efflux pump activity and low tumor penetration. Furthermore, the pharmacology of SAHA is particularly complex as it can act as an enzyme inducer following repeated dosing, increasing HDAC levels and may modify its own kinetics.
  • 573
  • 02 Dec 2021
Topic Review
S100P-Induced Cell Migration and Metastasis
The presence of S100P protein in cancer cells is strongly associated with reduced survival times of patients suffering from a number of cancers. It has been shown previously that S100P is a potent inducer of metastasis in a model system and it is likely that this metastasis-inducing ability underlies its association with reduced patient survival. However, the molecular mechanisms involved in S100P-driven metastasis are only now beginning to be elucidated and the evidence points to S100P enhancing cell migration and cell invasion.  It is now shown that in the same cell system S100P enhances cell migration by two separate mechanisms. One pathway being intracellular, involves changes in the numbers of focal adhesions.  The second pathway occurs at the cell membrane and does not involve changes in the number of focal adhesions, but involves extracellular/membrane bound S100P and is inhibited by specific inhibitors of plasmin. Importantly, mutation of the C-terminal amino acid of S100P, not only abolishes both pathways, but also markedly reduces the metastasis-inducing ability of S100P, thus identifying a possible target for the reduction of S100P-induced metastasis.
  • 421
  • 27 Oct 2021
Topic Review
RUNX2 and Cancer
Runt-related transcription factor 2 (RUNX2) is critical for the modulation of chondrocyte osteoblast differentiation and hypertrophy. Recently discovered RUNX2 somatic mutations, expressional signatures of RUNX2 in normal tissues and tumors, and the prognostic and clinical significance of RUNX2 in many types of cancer have attracted attention and led RUNX2 to be considered a biomarker for cancer. Many discoveries have illustrated the indirect and direct biological functions of RUNX2 in orchestrating cancer stemness, cancer metastasis, angiogenesis, proliferation, and chemoresistance to anticancer compounds, warranting further exploration of the associated mechanisms to support the development of a novel therapeutic strategy. 
  • 290
  • 25 Apr 2023
Topic Review
ROS in Cancer Progression
Reactive oxygen species (ROS) play a pivotal role in biological processes and continuous ROS production in normal cells is controlled by the appropriate regulation between the silver lining of low and high ROS concentration mediated effects. Interestingly, ROS also dynamically influences the tumor microenvironment and is known to initiate cancer angiogenesis, metastasis, and survival at different concentrations. At moderate concentration, ROS activates the cancer cell survival signaling cascade involving mitogen-activated protein kinase/extracellular signal-regulated protein kinases 1/2 (MAPK/ERK1/2), p38, c-Jun N-terminal kinase (JNK), and phosphoinositide-3-kinase/ protein kinase B (PI3K/Akt), which in turn activate the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), matrix metalloproteinases (MMPs), and vascular endothelial growth factor (VEGF). At high concentrations, ROS can cause cancer cell apoptosis. Hence, it critically depends upon the ROS levels, to either augment tumorigenesis or lead to apoptosis.
  • 585
  • 03 Aug 2021
Topic Review
ROS and Enzymatic Antioxidants in Small Domestic Ruminants
Oxygen is a fundamental element in aerobic life and oxidative metabolism representing the principal energy source for aerobic cells. Reactive oxygen species (ROS) are generated by a variety of cellular metabolic activities and as a by-product of ATP generation mediated by mitochondrial respiration. ROS are engaged in many redox-governing cell activities for the preservation of cellular homeostasis.
  • 290
  • 25 Jul 2023
Topic Review
Roles of PI3K/AKT/mTOR Axis in Arteriovenous Fistula
Renal failure is a worldwide disease with a continuously increasing prevalence and involving a rising need for long-term treatment, mainly by haemodialysis. Arteriovenous fistula (AVF) is the favourite type of vascular access for haemodialysis; however, the lasting success of this therapy depends on its maturation, which is directly influenced by many concomitant processes such as vein wall thickening or inflammation. Understanding the molecular mechanisms that drive AVF maturation and failure can highlight new or combinatorial drugs for more personalized therapy. 
  • 316
  • 14 Mar 2022
  • Page
  • of
  • 161
Video Production Service